Stocks

Stocks

The table gives an overview of all stocks, alphabetically sorted.

Show advanced options

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Name	Symbol	Analysis date	Close	+/- %
A Paradise Acquisition	APAD	Jan 16, 2026	10.02	0.00
A Paradise Acquisition Unit	APADU	Jan 16, 2026	10.30	0.00
A-Mark Precious Metals	AMRK	Jan 16, 2026	29.25	0.00
a.k.a Brands	AKA	Jan 16, 2026	11.90	+0.85
A.O Smith	AOS	Jan 16, 2026	72.48	+0.68
A10 Networks	ATEN	Jan 16, 2026	17.31	-1.54
A2Z Cust2Mate Solutions	AZ	Jan 16, 2026	7.35	+1.52
AA Mission Acquisition	AAM	Jan 16, 2026	10.68	0.00
AA Mission Acquisition II Class A	YCY	Jan 16, 2026	10.02	0.00
AAA - A Rated Corporate Bond Ishares	QLTA	Jan 16, 2026	48.18	-0.21
AAON	AAON	Jan 16, 2026	94.08	+4.49
AAR	AIR	Jan 16, 2026	105.08	-0.62
Aardvark Therapeutics	AARD	Jan 16, 2026	15.37	+0.13
Abacus Global Management	ABL	Jan 16, 2026	8.47	0.00
Abbott Laboratories	ABT	Jan 16, 2026	121.76	-1.43
AbbVie	ABBV	Jan 16, 2026	214.35	-1.11
AbCellera Biologics	ABCL	Jan 16, 2026	4.12	-1.44
Abeona Therapeutics	ABEO	Jan 16, 2026	5.25	-3.67
Abercrombie & Fitch	ANF	Jan 16, 2026	104.13	-3.24
Aberdeen Asia-Pacificome Fund	FAX	Jan 16, 2026	15.43	+0.59
Aberdeen Australia Equity Fund	IAF	Jan 16, 2026	13.26	+0.53
Aberdeen Emerging Markets Fund	AEF	Jan 16, 2026	7.44	-0.53
Aberdeen Global Fund	FCO	Jan 16, 2026	3.04	+1.33
Aberdeen Global Infrastructure	ASGI	Jan 16, 2026	21.94	+0.60
Aberdeen Income Credit Strategies Fund	ACP	Jan 16, 2026	5.55	-0.36
Aberdeen Income Credit Strategies Pref	ACP-A	Jan 16, 2026	20.54	+0.05
Abits Group	ABTS	Jan 16, 2026	5.43	-1.27
Abivax SA - American Depositary Shares	ABVX	Jan 16, 2026	117.10	+0.26
Able View Global	ABLV	Jan 16, 2026	0.70	-5.14
ABM Industries	ABM	Jan 16, 2026	45.26	+0.49

Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.